Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  ProMIS Neurosciences, Inc.    PMN   CA74346M1095

PROMIS NEUROSCIENCES, INC.

(PMN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société PROMIS NEUROSCIENCES, INC.
02/03PROMIS NEUROSCIENCES : Offers Perspectives on Recent Progress in the Alzheimer's..
AQ
02/02PROMIS NEUROSCIENCES : Offers Perspectives on Recent Progress in the Alzheimer's..
PU
01/12ProMIS Neurosciences Announces Strategic Priorities for 2021
GL
2020PROMIS NEUROSCIENCES : Year in review, looking forward to 2021
PU
2020PROMIS NEUROSCIENCES : Completes offering of special warrants
AQ
2020PROMIS NEUROSCIENCES : Completes Offering of Special Warrants
AQ
2020ProMIS Neurosciences Completes Offering of Special Warrants
GL
2020PROMIS NEUROSCIENCES : Completes offering of special warrants
PU
2020PROMIS NEUROSCIENCES : Announces Third Quarter 2020 Results
PU
2020PROMIS NEUROSCIENCES : Announces Third Quarter 2020 Results
AQ
2020PROMIS NEUROSCIENCES : Announces Third Quarter 2020 Results
AQ
2020ProMIS Neurosciences Announces Third Quarter 2020 Results
GL
2020PROMIS NEUROSCIENCES : offers comments on recent FDA Advisory Committee meeting ..
PU
2020PROMIS NEUROSCIENCES : offers comments on recent FDA Advisory Committee meeting ..
AQ
2020PROMIS NEUROSCIENCES : offers comments on recent FDA Advisory Committee meeting ..
AQ
2020ProMIS Neurosciences offers comments on recent FDA Advisory Committee meeting..
GL
2020PROMIS NEUROSCIENCES : Closes first tranche of private placement
PU
2020PROMIS NEUROSCIENCES : Closes First Tranche of Private Placement
AQ
2020ProMIS Neurosciences Closes First Tranche of Private Placement
GL
2020PROMIS NEUROSCIENCES : Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Research S..
AQ
2020PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board
AQ
2020PROMIS NEUROSCIENCES : rsquo; Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Res..
AQ
2020PROMIS NEUROSCIENCES : rsquo; Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Res..
AQ
2020ProMIS Neurosciences' Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Research..
GL
2020PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board
PU
2020PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board
AQ
2020PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board
AQ
2020ProMIS Neurosciences adds Dr. David Wishart to its Scientific Advisory Board
GL
2020PROMIS NEUROSCIENCES : Announces up to $3 million private placement offering of ..
AQ
2020PROMIS NEUROSCIENCES : Announces up to $3 million private placement offering of ..
PU
2020PROMIS NEUROSCIENCES : Announces Up to $3 Million Private Placement Offering of ..
AQ
2020ProMIS Neurosciences Announces Up to $3 Million Private Placement Offering of..
GL
2020PROMIS NEUROSCIENCES' PERSPECTIVE ON : is approval likely?
PU
2020PROMIS NEUROSCIENCES : Offers its Perspective on the Likelihood of Regulatory Ap..
AQ
2020PROMIS NEUROSCIENCES : Offers its Perspective on the Likelihood of Regulatory Ap..
AQ
2020ProMIS Neurosciences Offers its Perspective on the Likelihood of Regulatory A..
GL
2020PROMIS NEUROSCIENCES : Neil Cashman to Speak at Protein Misfolding Drug Discover..
AQ
2020PROMIS NEUROSCIENCES : rsquo; Neil Cashman to Speak at Protein Misfolding Drug D..
AQ
2020PROMIS NEUROSCIENCES : rsquo; Neil Cashman to Speak at Protein Misfolding Drug D..
AQ
2020ProMIS Neurosciences' Neil Cashman to Speak at Protein Misfolding Drug Disco..
GL
2020PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease
AQ
2020PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease
PU
2020PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease
AQ
2020PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease
AQ
2020ProMIS Neurosciences to develop multivalent vaccine for Alzheimer's disease
GL
2020PROMIS NEUROSCIENCES : to Participate in H.C. Wainwright & Co. 22nd Annual Inves..
AQ
2020PROMIS NEUROSCIENCES : to Participate in H.C. Wainwright & Co. 22nd Annual Inves..
AQ
2020ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 22nd Annual Inve..
GL
2020ProMIS Neurosciences Announces Second Quarter 2020 Results
GL
2020PROMIS NEUROSCIENCES : CEO memorandum to ProMIS shareholders, August 11, 2020
PU
2020ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders
GL
2020PROMIS NEUROSCIENCES : and BC Neuroimmunology announce revenue-sharing joint ven..
AQ
2020ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint ve..
GL
2020ProMIS Neurosciences announces adjournment and change of location of annual m..
GL
2020ProMIS Neurosciences and collaborator BC Neuroimmunology announce significant..
GL
2020ProMIS Neurosciences and collaborative team receive Supercluster Award suppor..
GL
2020PROMIS NEUROSCIENCES : Chairman's Update details new programs from expanded use ..
AQ
2020PROMIS NEUROSCIENCES : and BC Neuroimmunology expand collaboration to develop an..
AQ
2020PROMIS NEUROSCIENCES : Chairman's Memorandum, May 20, 2020
PU
2020ProMIS Neurosciences Chairman's Update details new programs from expanded use..
GL
2020ProMIS Neurosciences and BC Neuroimmunology expand collaboration to develop a..
GL
2020ProMIS Neurosciences Announces First Quarter 2020 Results
GL
2020ProMIS Neurosciences identifies multiple novel targets on SARS CoV-2 for deve..
GL
2020ProMIS Neurosciences develops novel antagonists for RACK1, a protein involved..
GL
2020ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dement..
GL
2020PROMIS NEUROSCIENCES : commends Biogen for clarifying aducanumab regulatory fili..
AQ
2020ProMIS Neurosciences announces collaboration to develop serological test to a..
GL
2020PROMIS NEUROSCIENCES : Journal of the American Academy of Neurology Publishes Pr..
AQ
2020PROMIS NEUROSCIENCES : Journal of the American Academy of Neurology Publishes Pr..
AQ
2020Journal of the American Academy of Neurology Publishes ProMIS Neurosciences' ..
GL
2020ProMIS Neurosciences to Present Data and Moderate Session at AAIC 2020
GL
2020PROMIS NEUROSCIENCES : Announces approval for warrant repricing
AQ
2020ProMIS Neurosciences Announces Fiscal Year 2019 Annual Results
GL
2020PROMIS NEUROSCIENCES : initiates Natural History Study of Blood-Based Biomarkers..
AQ
2020ProMIS Neurosciences Initiates Natural History Study of Blood-Based Biomarker..
GL
1  2  3Next
Upcoming event on PROMIS NEUROSCIENCES, INC.